clonazepam has been researched along with zopiclone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Cooper, SJ; Estall, LB | 1 |
| Paz, L; Peter, Y; Pick, CG; Toren, P; Weizman, R | 1 |
| Sicot, R | 1 |
| Dickson, SJ; Irving, RC | 1 |
| Csonka, A; Makkos, Z | 1 |
| Harrison-Woolrych, M; McLean, RM | 1 |
| Anderson, KN; Shneerson, JM | 1 |
| Gadit, A | 1 |
| Aursnes, I; Bjørner, T; Skomedal, T; Tvete, IF | 1 |
| Chen, H; He, J; Liu, Y; Luan, X; Qiu, H; Shen, H; Tu, X; Zhao, K; Zhu, Z | 1 |
14 other study(ies) available for clonazepam and zopiclone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Differential effects of benzodiazepine receptor ligands on isotonic saline and water consumption in water-deprived rats.
Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Drinking; Hypnotics and Sedatives; Male; Piperazines; Pyrazoles; Rats; Receptors, GABA-A; Sodium Chloride; Time Factors; Water; Water Deprivation | 1987 |
Behavioral effects of agents active at the gamma-aminobutyric acid receptor complex in the staircase paradigm.
Topics: Acetates; Adjuvants, Immunologic; Amines; Animals; Anti-Anxiety Agents; Anxiety; Azabicyclo Compounds; Behavior, Animal; Brain; Clonazepam; Cyclohexanecarboxylic Acids; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Exploratory Behavior; Flumazenil; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Mice; Mice, Inbred ICR; Motor Activity; Neurons; Piperazines; Receptors, GABA-A | 2001 |
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
[Akathisia in the course of olanzapine treatment].
Topics: Aged; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Olanzapine; Patient Admission; Piperazines; Schizophrenia; Treatment Outcome | 2006 |
Alopecia associated with quetiapine.
Topics: Adult; Affective Disorders, Psychotic; Alopecia; Antipsychotic Agents; Azabicyclo Compounds; Bipolar Disorder; Citalopram; Clonazepam; Dibenzothiazepines; Female; Humans; Hypnotics and Sedatives; Piperazines; Quetiapine Fumarate | 2007 |
Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam.
Topics: Adjuvants, Anesthesia; Aged; Azabicyclo Compounds; Central Nervous System Depressants; Clonazepam; Cohort Studies; Female; Follow-Up Studies; GABA Modulators; Humans; Hypnotics and Sedatives; Male; Melatonin; Piperazines; Polysomnography; REM Sleep Behavior Disorder; Retrospective Studies; Severity of Illness Index; Sodium Oxybate; Surveys and Questionnaires; United Kingdom | 2009 |
Persistent genital arousal disorder: a clinical challenge.
Topics: Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Citalopram; Clonazepam; Female; GABA Modulators; Humans; Hypnotics and Sedatives; Middle Aged; Piperazines; Psychotherapy; Sexual Dysfunctions, Psychological; Treatment Failure | 2013 |
[Dispensing of benzodiazepines and Z drugs by Norwegian pharmacies 2004-2011].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Drug Prescriptions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Norway; Pharmaceutical Services; Piperazines; Practice Guidelines as Topic; Pyridines; Registries; Sex Factors; Zolpidem | 2013 |
Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months.
Topics: Adult; Antidepressive Agents; Azabicyclo Compounds; Biomarkers; Case-Control Studies; Chronic Disease; Clonazepam; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Odds Ratio; Piperazines; Prognosis; Pyridines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Zolpidem | 2017 |